The Access to Medicine Index is a very important project. What gets measured, gets done.
NEW: 1ST INDEPENDENT FRAMEWORK FOR ASSESSING PHARMA ON AMR
The methodology for the 2018 Antimicrobial Resistance Benchmark will evaluate how pharmaceutical companies are responding to the rising threat from AMR. It will map the actions of 30 companies against agreed priorities for limiting AMR, structured around three Research Areas. Read more >>
News and Events
24 Aug 2017
18 May 2017
21 Apr 2017
06 Mar 2017
13 Dec 2016
Access to medicine: a material issue for investors
Investors engage with the Foundation for insight into our analysis of the pharma sector, including into governance structures, R&D and pricing strategies.
The foundation on Twitter
“To improve access, we believe pharmaceutical companies need to focus on how
they deploy their products, and, as global citizens, collaborate on the development of strong health systems.”
Jayasree K. Iyer, Executive Director, Access to Medicine Foundation.
The Access to Medicine Foundation and its publications are funded by